Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1680
    +0.0024 (+0.20%)
     

  • GBP/USD

    1.2499
    -0.0012 (-0.09%)
     

  • Bitcoin GBP

    51,100.11
    -803.19 (-1.55%)
     

  • CMC Crypto 200

    1,329.66
    -66.87 (-4.79%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,351.50
    +9.00 (+0.38%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Is Cresco Labs Stock a Buy?

Sushree Mohanty, The Motley Fool
·4-min read
Is Cresco Labs Stock a Buy?

When you think about marijuana stocks, popular Canadian cannabis companies including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) likely come to mind. Illinois-based Cresco Labs (OTC: CRLBF) had an impressive start to the year with its first-quarter results, and it continued to shine with its stunning second-quarter results, reported on Aug. 20. Shares of Cresco are down 20% so far this year, while Aurora's and Canopy's shares have lost 73% and 22%, respectively.

Continue reading